Keratoconus is the most common corneal dystrophy found in the United States. It is characterized by a progressive thinning and distortion of the cornea.
The cornea begins to bulge outward causing nearsightedness and astigmatism. In more advanced cases the cornea becomes cone-shaped and vision is affected. Keratoconus usually affects both eyes. In many cases, it may be possible to improve the vision with special contact lenses. Unfortunately, for about 20% of patients, contact lenses do not work well and a corneal transplant may be necessary. A new treatment for Keratoconus known as Collagen Crosslinking has been FDA approved for use in the United States. EMG offers the only FDA approved treatment using the Avedro crosslinking system and Photrexa.
If Collagen Crosslinking or a Corneal Transplant should be considered for your Keratoconus, Dr. Sise will take all the time necessary to explain the risks, benefits, and likelihood of success in your particular situation. Please be assured that all of your questions will be answered so that you can make an educated and informed decision about your treatment options at Eyecare Medical Group.